FDA approves new pancreatic cancer drug that could extend patients' lives
Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.
Watch CBS News
Deputies and volunteers searched through the night for a 9-year-old girl who disappeared from her Paulding County neighborhood Wednesday evening.
The Dolly Parton tributes continued Wednesday evening at Jolene Jolene in Atlanta's Kirkwood neighborhood.
For the first time in Georgia, parents who feel they have nowhere to turn will have a way to safely and anonymously surrender their newborns.
After experiencing addiction, prison, and homelessness, a Georgia family was able to buy their first house. Thanks to a nonprofit, they can start their new lives with fully-furnished rooms.
Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.